Cost-effectiveness of trastuzumab deruxtecan for previously treated HER2-low advanced breast cancer

• Demin Shi ,

  Contributed equally to this work with: Demin Shi, Xueyan Liang

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Writing – original draft

  Affiliation Department of Reproductive Medicine, The People’s Hospital of Hechi, Hechi, Guangxi, People’s Republic of China

  ⨯
• Xueyan Liang ,

  Contributed equally to this work with: Demin Shi, Xueyan Liang

  Roles Conceptualization, Formal analysis, Methodology, Project administration, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Department of Pharmacy, Guangxi Academy of Medical Sciences and the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People’s Republic of China

  ⨯
• Yan Li,

  Roles Data curation, Formal analysis, Methodology, Software, Supervision, Writing – review & editing

  Affiliation Department of Pharmacy, Guangxi Academy of Medical Sciences and the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People’s Republic of China

  ⨯
• Lingyuan Chen

  Roles Conceptualization, Funding acquisition, Project administration, Supervision, Writing – review & editing

  * E-mail: lingyuanchen@outlook.com

  Affiliation Department of Pharmacy, The People’s Hospital of Hechi, Hechi, Guangxi, People’s Republic of China

  https://orcid.org/0000-0002-2266-0013

  ⨯